Selank: A Synthetic Tuftsin-Analog Peptide in Neuropeptide Research

Selank is a synthetic peptide studied in neuropeptide research, best known as a stabilized analog of the immunomodulatory fragment tuftsin. It is one of a small group of peptides originally developed in Russian research programs and now widely discussed in the research-peptide community. As always, the framing matters: the material discussed here is research material for laboratory use only — not for human or veterinary use, and not a medicine.

What is selank?

Selank is a heptapeptide based on tuftsin, a naturally occurring immunopeptide, extended with a Pro-Gly-Pro sequence that improves stability against enzymatic breakdown. That stabilization is the whole point of the design — tuftsin itself is short-lived, and the added residues let researchers study the molecule over a usable timeframe without changing its core.

Proposed mechanisms under study

In research settings, selank has been examined in the context of GABAergic and monoaminergic signaling, expression of neurotrophic factors such as BDNF, and immune-modulating activity inherited from its tuftsin origin. These are areas of investigation, not settled conclusions: most of the work sits at the in-vitro and animal-model tiers, and the picture is still being assembled.

How the evidence is layered

Much of the published selank literature originates from Russian research groups, with limited large-scale independent clinical replication in the Western literature. That does not make the research uninteresting, but it does mean claims should be read with the evidence tier attached: mechanistic and animal-model findings are not the same as established human clinical outcomes, and research-grade material is not a therapeutic in any case.

Selank and semax

Selank is frequently discussed alongside semax, another short synthetic neuropeptide from the same research tradition. They are distinct molecules with different parent sequences — selank from tuftsin, semax from a fragment of ACTH — so despite often appearing together, a Certificate of Analysis for one says nothing about the other.

Identity and purity: reading the data

For any short synthetic peptide, two questions decide quality. Is it the right molecule? — identity by mass spectrometry (LC-MS). How pure is it? — by HPLC. A certificate can show one without the other, which is why understanding HPLC vs LC-MS: what each one proves and how to spot a fake peptide COA matters. The Free Noverix Guide covers this terminology in plain language.

Research use only

Selank research material is provided strictly for in-vitro and laboratory research. It is not a medicine, not a supplement, and not intended or authorized for human or veterinary use, nor to diagnose, treat, cure, or prevent any disease.